【レポートの概要（一部）】
1. Report Overview
1.1 Overview of Findings: World Market Overview 2015 to 2026
1.2 Why You Should Read This Report
1.3 How This Report Delivers: Chapter Outlines
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About visiongain
2. Introduction to Parkinson’s Disease and its Treatments
2.1 What Causes Parkinson’s?
2.2 Motor Symptoms of Parkinson’s Disease
2.2.1 Tremor: The First Sign of PD
2.2.2 Uncontrolled Muscle Contractions Cause Rigidity
2.2.3 Bradykinesia: The Most Characteristic Feature of Parkinson’s
2.2.4 Postural Instability Manifests as PD Progresses
2.3 Neuropsychiatric Symptoms are Common in PD Patients
2.3.1 Behavioural Deficits are Often the Most Widespread
2.3.2 Cognitive Impairment can Impede Daily Tasks
2.3.3 Autonomic Dysfunction: Another Common Occurrence
2.4 Other Symptoms Associated with Parkinson’s
2.5 Parkinson’s Disease: Diagnosis and Treatment
2.5.1 Diagnosis is Difficult
2.5.2 Treatment Options – Therapeutic Classes
3. Parkinson’s Disease: World Drugs Market, 2016-2026
3.1 Sales of the Overall World PD Drugs Market, 2015-2026
3.2 Parkinson’s Disease: Market Segmentation, 2015
3.3 Overall PD Drug Market: Commercial Drivers and Restraints
3.4 Dopaminergic Agents: Foundation of PD Treatment
3.4.1 Levodopa Therapy
3.4.2 Patent Expiries Affect the Market
3.4.3 New Levodopa Therapies on the Horizon
3.4.4 Dopaminergic Agents: Market Projections to 2026
3.5 Dopamine Receptor Agonists: The Leading Class in 2016
3.5.1 Dopamine Agonists: A Front Line Drug
3.5.2 Advantages over L-Dopa Therapy
3.5.3 Leading Drugs in the Segment
3.5.4 A Healthy R&D Pipeline
3.5.5 Dopamine Receptor Agonists: Market Projections, 2016-2026
3.6 Catechol-O-Methyl Transferase (COMT) Inhibitors: A Popular Choice of Treatment
3.6.1 Entacapone: The Leading Drug in this Segment
3.6.2 Commercial Scope for COMT Inhibitors
3.6.3 COMT Inhibitors: Market Projections, 2016-2026
3.7 Are Monoamine Oxidase–B (MAO-B) Inhibitors Better Than COMT?
3.7.1 MAO-B Inhibitor Therapeutics in the Market
3.7.2 New MAO-B Products in Development
3.7.3 MAO-B Inhibitors: Market Projections, 2016-2026
3.7.4 Other Therapeutic Options: A Growing Opportunity
3.7.5 Generic Erosion in the PD Market
3.7.6 A Broad and Diverse Pharmaceutical Segment
3.7.7 Other Non-medication PD Therapies
3.7.8 The Pipeline Offers Disease Modifying Potential
3.7.9 Other Mechanisms of Action: Market Projections, 2016-2026
4. Leading Companies in the PD Drug Market, 2016
4.1 PD: Novartis sales of Stalevo/Comtan
4.1.1 Market Forecast for Comtan/Stalevo, 2016-2026
4.2 Teva’s Azilect: Past, Present and Future
4.2.1 Market Forecast for Azilect, 2015-2026
4.3 UCB’s Leading Neupro Patch Drug
4.3.1 Market Forecast for Neupro, 2016-2026
4.4 Other Market Players
5. The Leading National Markets, 2016-2026
5.1 Regional Breakdown of the World PD Drug Market, 2016
5.2 The World PD Drug Market: Regional Forecasts to 2026
5.3 The PD Drug Market in the US: The Largest Single National Market
5.3.1 Market Projections for the US, 2015-2026
5.4 The PD Drug Market in the Five Leading European National Markets (EU5), 2016-2026
5.4.1 Market Projections for the EU5, 2016-2026
5.4.2 EU5 Breakdown by Country, 2016
5.4.3 Market Projection for EU5 Countries, Regional Breakdown
5.4.4 Germany: The Largest EU5 Market
5.4.5 France: Strong Healthcare System – What’s Possible There?
5.4.6 UK’s Spending Restrictions Affect the PD Drugs Market
5.4.7 Spain – What Effects Will Austerity Have on PD Drug Sales?
5.4.8 The PD Drug Market in Italy: Rising and Ageing Population
5.5 Japan has the Highest Proportion of Over-65s in the World
5.5.1 Predictions for Japanese PD Drug Market, 2016-2026
5.6 PD Drug Market in Emerging Countries: Brazil, Russia, India and China (BRIC)
5.6.1 Breakdown of BRIC Revenues by Country, 2016
5.6.2 Market Projections for BRIC Nations’ PD Drug Sales, 2016-2026
5.6.3 Brazil’s Rapid Growth of the Pharma Market – What’s the Future?
5.6.4 Russia’s Healthcare Market Gives Generic Sales Opportunities
5.6.5 India: Generic Manufacturers Seek to Dominate the PD Market
5.6.6 China’s Ageing Population Stimulates Sales of PD-Treating Medicines
6. Research and Development for Treating Parkinson’s Disease
6.1 New Mechanisms of Action in the Late-Stage R&D Pipeline
6.2 Growing Potential of Marketed Products: Phase IV Studies
6.3 Phase III Clinical Products Promising Potential in the PD market
6.3.1 IPX203 (Impax Laboratories): The New Generation of Levodopa
6.3.2 Newron’s Safinamide Expected Launch in 2020
6.3.3 Pimavanserin: A First-in-Class Treatment for Parkinson’s Disease Psychosis
6.3.4 Istradefylline: A Promising A(2a) Receptor Antagonist
6.3.5 Termination of Preladenant, APromising A(2a) Receptor Antagonist
6.3.6 Levodopa/Carbidopa Intestinal Gel (LCIG)
6.3.7 Can Opicapone Compete with Existing COMT Inhibitors
6.3.8 Pitolisant: Addressing an Unmet Need
6.3.9 Northera: Oral Precursor of Norepinephrine
6.3.10 Targin by Mundipharm
6.3.11 Nurelinfor Levodopa-Induced Dyskinesia
6.3.12 SYN-115/120: Superior to Istradefylline?
6.4 Phase II PD Pipeline: Overview
6.4.1 Glutamatergic Drugs: Main Target for Pipeline Candidates
6.4.2 Fipamezole: Another Promising A(2a) Receptor Antagonist
6.4.3 CVT-301: A Novel Intrapulmonary Approach
6.4.4 DM-1992: Can Compete with Levodopa Reformulations?
6.4.5 The Accordion Pill Carbidopa/Levodopa by Intec Pharma
6.4.6 Orient Addresses Sialorrhoea
6.4.7 NH004: Formulated with a Muco-Adhesive Property
6.4.8 VR040: A Reformulation of Apomorphine
6.4.9 AVP-923: A Novel Approach for LID-PD
6.4.10 PD Giant Orion, Develop a New Levodopa Drug, ODM-101
6.4.11 News for NeuroDerm’s Reformulations
6.5 Phase I and Pre-clinical PD Pipeline: Overview
6.5.1 Vernalis’ A(2a) Receptor Antagonist Drug in Phase Ib/IIa
6.5.2 Sanofi Collaborates with The Michael J. Fox Foundation
6.5.3 UCL Show Exenatide Potential in Parkinson’s
6.5.4 Titan Pharmaceuticals Develop a Novel Platform
6.6 Neuroprotective Drugs Offer Hope
6.6.1 Phytopharm and Cogane Development
6.6.2 The Potential of Dietary Supplements
6.6.3 GCase Enzymes: Amicus and Biogen Strike A Deal for Parkinson’s
6.6.4 Research Finds Ursodeoxycholic Acid (UDCA) A Potential Cure for Parkinson’s
6.6.5 PD Biomarkers: Potential for Revolutionising Diagnosis and Treatment
6.6.6 Antibody Targeting: The Coming of Age
6.7 Gene Therapy: Promising Research and Technology
6.7.1 ProSavin: Leading Gene Therapy Product
6.7.2 CERE-120 Promises Repair of Damaged Dopaminergic Neurons
6.7.3 AAV-hAADC-2: Another Gene Therapy Contender
6.8 Parthenogenesis (International Stem Cell Corporation): A Promising Outlook for PD Technology
7. Qualitative Analysis of the PD Drug Market, 2016
7.1 SWOT Analysis of the PD Market
7.1.1 Strengths and Weaknesses in the PD Drug Industry in 2016
7.1.2 Opportunities and Threats There from 2016 Onwards
7.2 STEP Analysis of the PD Market
7.2.1 Social Implication of Living with PD
7.2.2 Technological Developments on the Horizon
7.2.3 Economic Pressures: Healthcare Budgeting
7.2.4 Political Issues: Patent Challenges, Data Exclusivity and Regulatory Pathways
8. Research Interviews
8.1 Interview with Dr. Russell Kern (Executive VP, Chief Scientific Officer): International Stem Cell Corporation, California, US
8.1.1 The Overall PD Market
8.1.2 Current Understanding of Stem Cell Therapy
8.1.3 ISCO’s Novel PD Programme
8.1.4 The Potential of Immune-Matching
8.1.5 The Controversy Surrounding Stem Cell Research
8.1.6 The Potential for Parthenogenesis in PD and Other Applications
8.2 Professor Jian Feng PhD, Department of Physiology and Biophysics, University at Buffalo, the State University of New York
8.2.1 A possible Cure
8.2.2 Future Potential: Research
9. Conclusions from the Research and Analysis
9.1 The World PD Market: Predictions to 2026
9.2 Which Therapeutic Class will Dominate the Market in 2026?
9.3 Disease Modification: The Ultimate Goal
9.4 The Future of the Industry and Market for Parkinson’s Medicines
【レポート販売概要】
■ タイトル：パーキンソン病治療薬の世界市場2016-2026■ 英文：Parkinson’s Diseases: World Drug Industry and Market 2016-2026
■ 発行日：2016年5月
■ 調査会社：visiongain
■ 商品コード：VGAIN60623
■ 調査対象地域：グローバル
- データ集録システムの世界市場展望2017-2026According to Stratistics MRC, the Global Data Acquisition System is accounted for $1.61 billion in 2017 and is expected to reach $2.69 billion by 2026 growing at a CAGR of 5.9% during the forecast period. Increased emphasis on energy efficiency, resource optimization, and cost of production, rise of big data, IoT, and industrial revolution 4.0 and technological advancement in data acquisition syst …
- Crestor（ACS/急性冠症候群）：医薬品市場予測及び分析（～2023）Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which are …
- SCRパワーコントローラーの世界市場予測（～2023年）The SCR power controller market is estimated to be worth USD 130.6 Million in 2017 and is expected to reach USD 171.3 Million by 2023, at a CAGR of 4.62% between 2017 and 2023. The growth of this market is propelled by the rising demand for digitization of SCR power controllers across various applications. The market for three-phase SCR power controllers is expected to grow at a higher CAGR than t …
- カナダの呼吸装置市場Canada Respiratory Devices Market Outlook to 2021 Summary GlobalData’s new report, "Canada Respiratory Devices Market Outlook to 2021", provides key market data on the Canada Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, …
- Von Willebrand Disease：グローバル臨床試験レビューH2, 2013Von Willebrand Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Von Willebrand Disease Global Clinical Trials Review, H2, 2013" provides data on the Von Willebrand Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Von Willebrand Disease. It includes an overview of the trial numbers and …
- Chlorinated Polyvinyl Chlorideの世界市場Chlorinated Polyvinyl Chloride (CAS 68648-82-8) Market Research Report 2013 presents comprehensive data on chlorinated polyvinyl chloride markets globally and regionally (Europe, Asia, North America etc.) The report includes chlorinated polyvinyl chloride description, covers its application areas and related patterns. It overviews chlorinated polyvinyl chloride market, names chlorinated polyvinyl …
- 交通システム及び分析市場（世界市場予測と分析）In transportation systems and analytics market research repot, transportation system is defined as a term which is composed of the solutions, products, and applications that helps in improving the efficiency of the system. Hyper-urbanization, globalization, and constantly changing travel demand have been the growth driver behind the increasing use of advanced system. The solutions such as transpor …
- 低カロリー甘味料の世界市場：ステビア、キシリトール、アスパルテーム、スクラロース、チクロ、サッカリン、アセスルファムＫThe global low-calorie sweeteners market will see significant growth in the next ten years, doubling in its size by 2025. Visiongain estimates that in 2015 the market will be worth $11.4bn. The major drivers of the low-calorie sweeteners market include the growing demand for diet food, increasing levels of obesity, diabetes and other metabolic disorders. Moreover, in a market environment where sug …
- eマーケティング（デジタルマーケティング）IT支出の世界市場About e-marketer IT spending The rapid growth of the Internet has made online platforms a popular choice for conducting business activities. The global Internet footprint has grown from 2.4 billion in 2013 to more than 3.5 billion in 2015. Most developed regions have Internet penetration of more than 80%, while developing regions are also gradually picking up pace. This penetration of the Internet …
- M2Mサービスの世界市場2017-2021About Machine-to-Machine M2M ServicesA machine-to-machine (M2M) platform is a programmed unit in which M2M applications and services are built on. Owing to the growing adoption of the Internet of Things (IoT) and M2M services, the demand for innovative M2M platforms to enable new M2M services (such as connected cars and smart homes) is increasing. Also, many small players are entering the global M …
- 世界の商用航空機用炭素ブレーキ市場動向（2014-2018）About Carbon Brakes Currently, lightweight and fuel-efficient aircraft are in demand. Aircraft manufacturers are endeavoring to make aircraft that meet the requirements of airline companies. Carbon brakes are one of the best substitutes for the traditional steel brakes because they are lightweight and have higher energy consumption capability. Previously, the cost of carbon brakes was high therefo …
- 世界の産業用計量装置市場2015The Global Industrial Weighing Equipment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Industrial Weighing Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Industrial Weighing Equipment market analysis is provided for the internationa …
- 屋外ビデオウォールの世界市場2019-2023About this market Narrow bezels provide seamless viewing experience and minimize the number of divisions caused by widened bezels. The mirrored tapes over narrow bezels help reflect images by hiding the tile lines to give viewers a bigger display with no attachments or divisions. Thus, the continuous effort of vendors to ensure a smooth and flawless video wall display will drive the global video w …
- 世界の軍隊・軍事IT、データ、コンピューティング市場動向2013-2023：市場のSWOT分析This SWOT analysis of Military IT, Data and Computing market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military IT, Data and Computing Market 2012-2022 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily acces …
- 2014年市場分析：イギリスの肝炎診断Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, A …
